Non-transferrin-bound iron assay system utilizing a conventional automated analyzer

Clinica Chimica Acta

Volumn 437, Issue , 2014, Pages 129-135

  Ito, Satoshi ^a   Ikuta, Katsuya ^a   Kato, Daisuke ^b   Shibusa, Kotoe ^a   Niizeki, Noriyasu ^a   Tanaka, Hiroki ^a   Addo, Lynda ^a   Toki, Yasumichi ^a   Hatayama, Mayumi ^a   Inamura, Junki ^a   Shindo, Motohiro ^a   Sasaki, Katsunori ^a   Iizuka, Naomi ^b   Fujiya, Mikihiro ^a   Torimoto, Yoshihiro ^a   Kohgo, Yutaka ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

^b SHINO TEST CORPORATION   (Japan)

Author keywords

Automated analyzer; Iron overload; Iron toxicity; Nitroso PSAP; Non transferrin bound iron; Quantification

Indexed keywords

IRON; NON TRANSFERRIN BOUND IRON; REAGENT; UNCLASSIFIED DRUG; TRANSFERRIN;

ARTICLE; ASSAY; AUTOANALYZER; CLINICAL ARTICLE; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH THROUGHPUT SCREENING; HUMAN; INTERMETHOD COMPARISON; LIMIT OF DETECTION; LIMIT OF QUANTITATION; NON TRANSFERRIN BOUND IRON ASSAY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; ANIMAL; BLOOD; BOVINE; CHEMICAL ANALYSIS; LABORATORY AUTOMATION; PROCEDURES; STANDARDS;

ANIMALS; AUTOMATION, LABORATORY; CATTLE; CHEMISTRY TECHNIQUES, ANALYTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; IRON; TRANSFERRIN;

EID: 84929131898     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2014.07.013     Document Type: Article

References (37)

1. Andrews N.C. Forging a field: the golden age of iron biology. Blood 2008, 112(2):219-230.
2. Kohgo Y., Ikuta K., Otake T., Torimoto T., Kato J. Body iron metabolism and pathophysiology of iron overload. Int J Hematol 2008, 88(1):7-15.
3. Garrick M.D., Garrick L.M. Cellular iron transport. Biochim Biophys Acta 2009, 1790(5):309-325.
4. Hentze M.W., Muckenthaler M.U., Galy B., Camaschella C. Two to tango: regulation of mammalian iron metabolism. Cell 2010, 142(1):24-38.
5. Hershko C., Graham G., Bates G.W., Rachmilewitz E.A. Non-specific serum iron in thalassaemia: an abnormal serum iron fraction of potential toxicity. Br J Haematol 1978, 40(2):255-263.
6. Hider R.C. Nature of nontransferrin-bound iron. Eur J Clin Invest 2002, 32(Suppl. 1):50-54.
7. Xu X., Zhang L., Shen D., Wu H., Liu Q. Oxygen-dependent oxidation of Fe(II) to Fe(III) and interaction of Fe(III) with bovine serum albumin, leading to a hysteretic effect on the fluorescence of bovine serum albumin. J Fluoresc 2008, 18(1):193-201.
8. Grootveld M., Bell J.D., Halliwell B., Aruoma O.I., Bomford A., Sadler P.J. Non-transferrin-bound iron in plasma or serum from patients with idiopathic hemochromatosis. Characterization by high performance liquid chromatography and nuclear magnetic resonance spectroscopy. J Biol Chem 1989, 264(8):4417-4422.
9. Esposito B.P., Breuer W., Sirankapracha P., Pootrakul P., Hershko C., Cabantchik Z.I. Plasma iron in iron overload: redox activity and susceptibility to chelation. Blood 2003, 102(7):2670-2677.
10. Brissot P., Ropert M., Le Lan C., Loréal O. Non-transferrin bound iron: a key role in iron overload and iron toxicity. Biochim Biophys Acta 2012, 1820(3):403-410.
11. Cabantchik Z.I., Breuer W., Zanninelli G., Cianciulli P. LPI-labile plasma iron in iron overload. Best Pract Res Clin Haematol 2005, 18(2):277-287.
12. Hershko C. Mechanism of iron toxicity. Food Nutr Bull 2007, 28(4 Suppl.):S500-S509.
13. Hershko C. Pathogenesis and management of iron toxicity in thalassemia. Ann N Y Acad Sci 2010, 1202:1-9.
14. Meo A., Ruggeri A., La Rosa M.A., Zanghi L., Morabito N., Duca L. Iron burden and liver fibrosis decrease during a long-term phlebotomy program and iron chelating treatment after bone marrow transplantation. Hemoglobin 2006, 30(1):131-137.
15. Breuer W., Hershko C., Cabantchik Z.I. The importance of non-transferrin bound iron in disorders of iron metabolism. Transfus Sci 2000, 23(3):185-192.
16. Gutteridge J.M., Rowley D.A., Halliwell B. Superoxide-dependent formation of hydroxyl radicals in the presence of iron salts. Detection of 'free' iron in biological systems by using bleomycin-dependent degradation of DNA. Biochem J 1981, 199(1):263-265.
17. Fargion S., Cappellini M.D., Sampietro M., Fiorelli G. Non-specific iron in patients with beta-thalassaemia trait and chronic active hepatitis. Scand J Haematol 1981, 26(2):161-167.
18. Singh S., Hider R.C., Porter J.B. A direct method for quantification of non-transferrin-bound iron. Anal Biochem 1990, 186(2):320-323.
19. Mumby S., Koizumi M., Taniguchi N., Gutteridge J.M.C. Reactive iron species in biological fluids activate the iron-sulphur cluster of aconitase. Biochim Biophys Acta 1998, 1380(1):102-108.
20. Kolb A.M., Smit N.P.M., Lentz-Ljuboje R., Osanto S., van Pelt J. Non-transferrin bound iron measurement is influenced by chelator concentration. Anal Biochem 2009, 385(1):13-19.
21. Gosriwatana I., Loreal O., Lu S., Brissot P., Porter J., Hider R.C. Quantification of non-transferrin-bound iron in the presence of unsaturated transferrin. Anal Biochem 1999, 273(2):212-220.
22. Sasaki K., Ikuta K., Tanaka H., Ohtake T., Torimoto Y., Fujiya M., et al. Improved quantification for non-transferrin-bound iron measurement using high-performance liquid chromatography by reducing iron contamination. Mol Med Rep 2011, 4(5):913-918.
23. Gutterridge K.M., Quinlan G.J., Evans T.W. Transient iron overload with bleomycin detectable iron in the plasma of patients with adult respiratory syndrome. Thorax 1994, 49:707-710.
24. Breuer W., Ermers M.J., Pootrakul P., Abramov A., Hershko C., Cabantchik Z.I. Desferrioxamine-chelatable iron, a component of serum non-transferrin-bound iron, used for assessing chelation therapy. Blood 2001, 97:792-798.
25. Livrea M.A., Tesoriere L., Pintaudi A.M., Calabrese A., Maggio A., Freisleben H.J., et al. Oxidative stress and antioxidant status in beta-thalassemia major: iron overload and depletion of lipid-soluble antioxidants. Blood 1996, 88:3608-3614.
26. Walter P.B., Fung E.B., Killilea D.W., Jiang Q., Hudes M., Madden J., et al. Oxidative stress and inflammation in iron-overloaded patients with beta-thalassaemia or sickle cell disease. Br J Haematol 2006, 135(2):254-263.
27. Armbruster D.A., Pry T. Limit of blank, limit of detection and limit of quantitation. Clin Biochem Rev 2008, 29(Suppl. 1):S49-S52.
28. Le Lan C., Loréal O., Cohen T., Ropert M., Glickstein H., Lainé F., et al. Redox active plasma iron in C282Y/C282Y hemochromatosis. Blood 2005, 105(11):4527-4531.
29. Breuer W., Cabantchik Z.I. A fluorescence-based one-step assay for serum non-transferrin-bound iron. Anal Biochem 2001, 299(2):194-202.
30. Hunt J.R., Zeng H. Iron absorption by heterozygous carriers of the HFE C282Y mutation associated with hemochromatosis. Am J Clin Nutr 2004, 80(4):924-931.
31. Dürken M., Nielsen P., Knobel S., Finckh B., Herrnring C., Dresow B., et al. Nontransferrin-bound iron in serum of patients receiving bone marrow transplants. Free Radic Biol Med 1997, 22(7):1159-1163.
32. Lee D.H., Liu D.Y., Jacobs D.R., Shin H.R., Song K., Lee I.K., et al. Common presence of non-transferrin-bound iron among patients with type 2 diabetes. Diabetes Care 2006, 29(5):1090-1095.
33. von Bonsdorff L., Lindeberg E., Sahlstedt L., Lehto J., Parkkinen J. Bleomycin-detectable iron assay for non-transferrin-bound iron in hematologic malignancies. Clin Chem 2002, 48:307-314.
34. Loréal O., Gosriwatana I., Guyader D., Porter J., Brissot P., Hider R.C. Determination of non-transferrin-bound iron in genetic hemochromatosis using a new HPLC-based method. J Hepatol 2000, 32(5):727-733.
35. Breuer W., Ronson A., Slotki I.N., Abramov A., Hershko C., Cabantchik Z.I. The assessment of serum non-transferrin-bound iron in chelation therapy and iron supplementation. Blood 2000, 95(9):2975-2982.
36. 3+ loading into transferrin by forming a soluble Fe(III)-phosphate complex: a potential non-transferrin bound iron species. J Inorg Biochem 2012, 110:1-7.
37. Goto T., Ikuta K., Inamoto Y., Kamoshita S., Yokohata E., Koyama D., et al. Hyperferritinemia after adult allogeneic hematopoietic cell transplantation: quantification of iron burden by determining non-transferrin-bound iron. Int J Hematol 2013, 97(1):125-134.